Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer’s Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer’s Disease
Authors
Keywords
Metformin, Alzheimer’s disease, AICAR, Oligomerization, <em class=EmphasisTypeItalic >C. elegans</em>
Journal
MOLECULAR NEUROBIOLOGY
Volume 54, Issue 7, Pages 5427-5439
Publisher
Springer Nature
Online
2016-09-05
DOI
10.1007/s12035-016-0085-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Down-Regulation of Amyloid-β Through AMPK Activation by Inhibitors of GSK-3β in SH-SY5Y and SH-SY5Y-AβPP695 Cells
- (2018) Zhiyou Cai et al. JOURNAL OF ALZHEIMERS DISEASE
- Insulin and Alzheimer's Disease: Untangling the Web
- (2018) Suzanne Craft et al. JOURNAL OF ALZHEIMERS DISEASE
- Cocoa Extracts Reduce Oligomerization of Amyloid-β: Implications for Cognitive Improvement in Alzheimer's Disease
- (2018) Jun Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Behavioral Phenotyping of a Transgenic Caenorhabditis Elegans Expressing Neuronal Amyloid-β
- (2017) Laura E. Dosanjh et al. JOURNAL OF ALZHEIMERS DISEASE
- Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer’s disease neuropathological deficits
- (2016) S A Shah et al. MOLECULAR PSYCHIATRY
- Cilostazol Modulates Autophagic Degradation of β-Amyloid Peptide via SIRT1-Coupled LKB1/AMPKα Signaling in Neuronal Cells
- (2016) So Youn Park et al. PLoS One
- Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy
- (2015) Valerie Askanas et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-κB activation: Use of insulin to attenuate metformin's effect
- (2015) Pasquale Picone et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Insulin resistance and cognitive dysfunction
- (2015) Lina Ma et al. CLINICA CHIMICA ACTA
- Resveratrol reduces amyloid-beta (Aβ1–42)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans
- (2015) Charlotte Regitz et al. EUROPEAN JOURNAL OF NUTRITION
- Aβ peptide secretion is reduced by Radix Polygalae-induced autophagy via activation of the AMPK/mTOR pathway
- (2015) HUAN ZHAO et al. Molecular Medicine Reports
- Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer's disease β-amyloid oligomerization
- (2015) Dongjie Wang et al. MOLECULAR NUTRITION & FOOD RESEARCH
- The role of type 2 diabetes in neurodegeneration
- (2015) Giuseppe Verdile et al. NEUROBIOLOGY OF DISEASE
- Diabetes and Alzheimer Disease, Two Overlapping Pathologies with the Same Background: Oxidative Stress
- (2015) Sergio Rosales-Corral et al. Oxidative Medicine and Cellular Longevity
- Aberrant insulin signaling in Alzheimer's disease: current knowledge
- (2015) Gaurav Bedse et al. Frontiers in Neuroscience
- Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
- (2014) Christiane Reitz et al. BIOCHEMICAL PHARMACOLOGY
- Signaling pathway cross talk in Alzheimer’s disease
- (2014) Juan A Godoy et al. Cell Communication and Signaling
- Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
- (2014) M. Yarchoan et al. DIABETES
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex
- (2014) Moritz M. Hettich et al. PLoS One
- Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2
- (2014) W. De Haes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells
- (2014) Shu-Feng Zhou et al. Drug Design Development and Therapy
- A semi-automated motion-tracking analysis of locomotion speed in the C. elegans transgenics overexpressing beta-amyloid in neurons
- (2014) Kevin Machino et al. Frontiers in Genetics
- Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease – How Anti-Diabetics Could be a Solution for Dementia
- (2014) Inês Sebastião et al. Frontiers in Endocrinology
- Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism
- (2013) Filipe Cabreiro et al. CELL
- Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
- (2013) E. M. Moore et al. DIABETES CARE
- Molecular mechanism of action of metformin: old or new insights?
- (2013) Graham Rena et al. DIABETOLOGIA
- Modeling neurodegenerative diseases in Caenorhabditis elegans
- (2013) Jia Li et al. EXPERIMENTAL NEUROLOGY
- The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Aβ Oligomers through Tau Phosphorylation
- (2013) Georges Mairet-Coello et al. NEURON
- Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease
- (2013) C. L. Masters et al. Cold Spring Harbor Perspectives in Medicine
- Functional α7β2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid β peptides
- (2012) Qiang Liu et al. BMC NEUROSCIENCE
- Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation
- (2012) Jing Wang et al. Cell Stem Cell
- Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β
- (2012) Hyejin Park et al. HUMAN MOLECULAR GENETICS
- Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
- (2012) Patrick Imfeld et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes
- (2012) Waqar Ahmad MOLECULAR NEUROBIOLOGY
- Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer’s disease
- (2012) Gawain McColl et al. Molecular Neurodegeneration
- Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
- (2012) Marina R. Picciotto et al. NEURON
- Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice
- (2012) Jiejie Li et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- WormScan: A Technique for High-Throughput Phenotypic Analysis of Caenorhabditis elegans
- (2012) Mark D. Mathew et al. PLoS One
- Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease
- (2011) H. Rheinallt Parri et al. BIOCHEMICAL PHARMACOLOGY
- Reserpine modulates neurotransmitter release to extend lifespan and alleviate age-dependent Aβ proteotoxicity in Caenorhabditis elegans
- (2011) Kopal Saharia et al. EXPERIMENTAL GERONTOLOGY
- Modeling human neurodegenerative diseases in transgenic systems
- (2011) Miguel A. Gama Sosa et al. HUMAN GENETICS
- STR-33, a Novel G Protein-coupled Receptor That Regulates Locomotion and Egg Laying inCaenorhabditis elegans
- (2011) Jeong-Eui Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer’s-like changes
- (2011) Amit Gupta et al. NEUROPHARMACOLOGY
- Is Alzheimer's Disease a Result of Presynaptic Failure? - Synaptic Dysfunctions Induced by Oligomeric β-Amyloid
- (2011) Volker Nimmrich et al. REVIEWS IN THE NEUROSCIENCES
- Amyloid oligomers: formation and toxicity of Aβ oligomers
- (2010) Masafumi Sakono et al. FEBS Journal
- Genetic Mechanisms of Coffee Extract Protection in a Caenorhabditis elegans Model of -Amyloid Peptide Toxicity
- (2010) V. Dostal et al. GENETICS
- Assaying β-amyloid Toxicity using a Transgenic C. elegans Model
- (2010) Vishantie Dostal et al. Jove-Journal of Visualized Experiments
- Bilobalide modulates serotonin-controlled behaviors in the nematode Caenorhabditis elegans
- (2009) Marishka K Brown et al. BMC NEUROSCIENCE
- The Caenorhabditis elegans Aβ1–42Model of Alzheimer Disease Predominantly Expresses Aβ3–42
- (2009) Gawain McColl et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription
- (2009) Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endothelial Nicotinic Acetylcholine Receptors and Angiogenesis
- (2009) John P. Cooke et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Levamisole resistance resolved at the single-channel level in Caenorhabditis elegans
- (2008) Hai Qian et al. FASEB JOURNAL
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology
- (2008) M. S. Beeri et al. NEUROLOGY
- Amyloid beta oligomers induce impairment of neuronal insulin receptors
- (2007) Wei-Qin Zhao et al. FASEB JOURNAL
- A Caenorhabditis elegans model of tau hyperphosphorylation: Induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau
- (2007) Roland Brandt et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation